- Committee chairs: Axel Glasmacher (CDDF, DE); Mark Lawler (CDDF,UK)
- Pawel Przewiezlikowski (Ryvu, PO)
- Birgit Wolf (Bayer, DE),
- Hendrik Nogai (Ryvu, PO)
- Susan Bhatti (Merck Healthcare, NL)
- Ewa Mark-Pawłowicz (Astrazeneca, PL)
Programme committee
The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.
